Topic:Ceftriaxone
Ceftriaxone is a third-generation cephalosporin antibiotic used in veterinary medicine, including in horses, for the treatment of bacterial infections. It functions by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. In equine medicine, ceftriaxone is employed to manage infections caused by susceptible bacteria, including respiratory, skin, and soft tissue infections. The pharmacokinetics of ceftriaxone in horses, such as absorption, distribution, metabolism, and excretion, are important for understanding its efficacy and safety profile in this species. This page compiles peer-reviewed research studies and scholarly articles that explore the use, pharmacological properties, and clinical implications of ceftriaxone in equine health care.
Detection and genomic characterization of a multidrug-resistant Salmonella Newport co-harbouring blaCMY-2, qnrB19 and mcr-9 from the diarrheic faeces of a foal. This study reports the genomic characterization of the multidrug resistant Salmonella Newport strain 195_20 recovered from the diarrheic faeces of a foal in Brazil and co-harbouring the mcr-9, blaCMY-2 and qnrB19 antibiotic resistance genes. Bacterial isolate positive for mobile colistin resistance gene (mcr-9) was submitted to antimicrobial susceptibility testing by disk diffusion and broth microdilution for colistin and polymyxin B. The isolate was submitted to whole genome sequencing by Illumina technology and Nanopore Sequencing. Conjugation assays, plasmid sizes determined by S1-PFGE and ...
Streptococcus equi subsp. equi meningitis, septicemia and subdural empyema in a child. Streptococcus equi subsp. equi is a group C β-hemolytic streptococcus, and is an invasive pathogen with a very restricted host, causing the equine infection known as 'strangles'. It is a poor colonizer in horses, preferentially causing invasion and infection, compared with its ancestor Streptococcus equi subsp. zooepidemicus, which is considered an opportunistic commensal of the equine upper respiratory tract. In humans, S. equi subsp. equi causes invasive infections in immunocompromised hosts, often following close contact with horses. Such infections are associated with a high mortality, as...
Pharmacokinetics of ceftriaxone in healthy horses. Five healthy Equidae (4 horses and one pony) were given a single i.v. dose of ceftriaxone (50 mg/kg bwt) to determine the pharmacokinetics and concentration in cerebrospinal fluid (CSF). Blood was drawn from an i.v. jugular catheter and CSF from a pre-placed, intrathecal catheter. Serum and CSF concentrations were determined by high performance liquid chromatography. The mean serum concentration of ceftriaxone was 144.7 micrograms/ml 15 min after injection and declined to 0.3 microgram/ml 10 h after injection. The elimination rate constant (lambda 2) was 0.63 +/- s.e. 0.23/h, the elimination h...